Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy

oleh: Yan Xiaomin, Chen Junhao, Chen Guangmei, Zhao Qi, Liu Yong, Wu Chao, Zhou Yi-Hua, Huang Zuhu

Format: Article
Diterbitkan: BMC 2010-12-01

Deskripsi

<p>Abstract</p> <p>Background</p> <p>We aimed to clarify whether soluble CD40 ligand (sCD40L) activated B cells may be loaded with HBcAg18-27 peptide and served as antigen-producing cells (APCs) to induce HBV-specific cytolytic T lymphocytes (CTLs).</p> <p>Results</p> <p>Human B cells could be cultured in the presence of sCD40L up to 54 days, and the proportion of B cells in the S phase increased from 0% to 8.34% in the culture. The expression of CD80, CD86, major histocompatibility complex (MHC) classes I and II molecules on the sCD40L-activated B cell was significantly increased after long-time culture. Cytometry and fluorescence microscopy showed that more than 98% sCD40L-activated B cells were loaded by the HBcAg peptide. Furthermore, the peptide-pulsed activated B cells could induce HBcAg18-27 specific CTLs.</p> <p>Conclusions</p> <p>Our results demonstrate that sCD40L-activated B cells may function as APCs and induce HBV-specific CTLs.</p>